New Immunosuppressive Therapies in Uveitis Treatment
Uveitis is an inflammatory process that initially starts in the uvea, but can also affect other adjacent eye structures, and is currently the fourth cause of blindness in developed countries. Corticoids are probably the most widespread treatment, but resorting to other immunosuppressive treatments i...
Main Authors: | Salvador Mérida, Elena Palacios, Amparo Navea, Francisco Bosch-Morell |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/16/8/18778 |
Similar Items
-
Immunosuppressive therapy in non-infections uveitis and retinovasculitis
by: E. A. Drozdova
Published: (2014-07-01) -
Immunosuppressive therapy in non-infections uveitis and retinovasculitis
by: E. A. Drozdova
Published: (2014-07-01) -
Immunosuppressives and biologicals in uveitis: The way forward – Current concepts
by: Karpagam Damodaran, et al.
Published: (2019-01-01) -
Systemic immunosuppressive therapies for uveitis in developing countries
by: Hitesh Agrawal, et al.
Published: (2020-01-01) -
Tubulointerstitial nephritis and uveitis syndrome: An atypical case
by: Silvia Cunha Diniz, et al.
Published: (2020-01-01)